NSCLC (non small-cell lung cancer)

/Tag:NSCLC (non small-cell lung cancer)

Abstract Number: 745

THE ERA OF IMMUNOTHERAPY IN CANCER: 2 CASE REPORTS OF IMMUNE RELATED ADVERSE EVENTS SECONDARY TO PEMBROLIZUMAB

Case Presentation: Case1: A 72- year old male with a diagnosis of stage four non-small cell Lung carcinoma who was treated with Pembrolizumab, presented two weeks after his first dose with generalized body aches and [...]

By | 2019-03-11T14:34:44-04:00 March 11th, 2019|Adult, Clinical Vignettes, Hospital Medicine 2019|Comments Off on THE ERA OF IMMUNOTHERAPY IN CANCER: 2 CASE REPORTS OF IMMUNE RELATED ADVERSE EVENTS SECONDARY TO PEMBROLIZUMAB